We have examined the incidence of new antioxidant compounds, so-called
lazaroids, on the morphological and biochemical aspects of differenti
ation of C2 mouse skeletal muscle cells. We show that three lazaroids
(U-74006F U-74389F and U-83836E) enhance fusion of myogenic cells when
added at the day of fusion. A parallel increase in nicotinic acetylch
oline receptor expression and skeletal muscle a-actin content was obse
rved. This promoting effect of lazaroids on myogenesis could be relate
d to inhibition of free radical-mediated muscle damage. Therefore, one
could expect that lazaroids might he useful in the treatment of degen
erating muscle diseases such as Duchenne muscular dystrophy.